Healthcare Stocks Move in Friday's After-Market Session

Venus Concept VERO stock increased 45.1% to $3.12, while Pliant Therapeutics PLRX stock rose 20.0% to $1.5. Sera Prognostics SERA stock declined 25.2% to $3.06, and Odysight ai ODYS shares decreased 18.55% to $5.71. Inhibikase Therapeutics IKT shares fell 16.05% to $1.36, and Autonomix Medical AMIX stock fell 15.43% to $1.7. Oragenics OGEN stock decreased 12.1% to $3.56, and Synaptogenix SNPX shares declined 7.2% to $5.61.

Title: After-Hours Market Movements: Key Stocks Show Significant Gains and Losses

June 19, 2025 - The after-hours trading session on Friday saw a mix of notable gains and losses among several biotechnology and healthcare stocks. Venus Concept Inc. (NASDAQ: VERO) led the pack with a remarkable 45.4% increase, while Pliant Therapeutics Inc. (NASDAQ: PLRX) rose 21.6% to $1.52. Conversely, Sera Prognostics Inc. (NASDAQ: SERA) experienced a significant decline of 24.21% to $3.10, and other stocks such as Odysight AI (NASDAQ: ODYS), Inhibikase Therapeutics Inc. (NASDAQ: IKT), Autonomix Medical Inc. (NASDAQ: AMIX), Oragenics Inc. (NYSEARCA: OGEN), and Synaptogenix Inc. (NASDAQ: SNPX) also saw substantial drops.

Venus Concept Inc. (NASDAQ: VERO) saw its stock price increase by 45.4% to $3.12 during the after-hours session. This surge comes after a 20.73% drop over the past three months, indicating a strong recovery in investor sentiment.

Pliant Therapeutics Inc. (NASDAQ: PLRX) experienced a 21.6% increase to $1.52. The company had earlier announced a pause in the development of its drug candidate, bexotegrast, due to unsatisfactory results in phase 2b/3 trials. However, the stock's after-hours performance suggests optimism about the company's shift in focus to PLN-101095, a promising drug for solid tumors [1].

Sera Prognostics Inc. (NASDAQ: SERA) saw its stock price drop by 24.21% to $3.10. Despite the decline, the stock had a notable 107.0% increase earlier in the day, indicating volatility in the market. Wall Street Zen recently upgraded the stock to a "Hold" rating from a "Sell" rating, suggesting a more cautious outlook [3].

Odysight AI (NASDAQ: ODYS) experienced an 18.55% decrease to $5.71, while Inhibikase Therapeutics Inc. (NASDAQ: IKT) fell 16.05% to $1.36. Both companies saw significant losses during the regular trading session, with ODYS down 11.95% and IKT down 11.68%.

Autonomix Medical Inc. (NASDAQ: AMIX) dropped 15.43% to $1.70, experiencing a correction after a 60.8% loss in regular trading hours. The stock has shown volatility with a 10.1% increase in the regular trading session followed by a 15.92% decrease in after-hours trading.

Oragenics Inc. (NYSEARCA: OGEN) saw a 14.32% decrease to $3.47, despite a strong 16.05% gain earlier in the day. The stock is trading 61.21% higher than a month ago, indicating a mixed performance.

Synaptogenix Inc. (NASDAQ: SNPX) declined 7.2% to $5.61, following a 10.1% increase in the regular trading session. The stock has been volatile, with a 32.1% decrease in the past year.

These after-hours movements reflect the ongoing volatility and investor sentiment shifts in the biotechnology and healthcare sectors. Investors should closely monitor these stocks for further developments and updates.

References:
[1] https://www.gurufocus.com/news/2951209/pliant-therapeutics-plrx-halts-development-of-key-drug-after-trial-setback
[2] https://www.chartmill.com/news/AVAV/Chartmill-30515-Get-insights-into-the-top-gainers-and-losers-of-Fridays-after-hours-session
[3] https://www.marketbeat.com/instant-alerts/sera-prognostics-nasdaqsera-rating-increased-to-hold-at-wall-street-zen-2025-06-21/